Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Injection of hydrocortisone acetate into shoulder joint |
Direct substance |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Injection of hydrocortisone acetate into ankle joint |
Direct substance |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Injection of hydrocortisone acetate into knee joint |
Direct substance |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 100 mg/mL rectal foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Hydrocortisone acetate 25 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Hydrocortisone acetate [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat 25 mg/ml injektionsvæske, suspension, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Hydrocortisone acetate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Hydrocortisone acetate 5 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 25 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat øjensalve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat 1 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Hydrocortisone acetate 10 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Hydrocortisone acetate [topical] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat 2,5 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat 0,5 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Hydrocortisone 1% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Hydrocortisone acetate 50mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat 30 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat 5 mg + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat + neomycinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Subcutaneous injection of hydrocortisone acetate |
Direct substance |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
hydrocortisonacetat + pramoxinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat + pramoxinhydrochlorid 1 % wt/vol/1 % wt/vol lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat + pramoxinhydrochlorid 1 % wt/wt/1 % wt/wt aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat 2,5 % wt/wt + pramoxinhydrochlorid 1 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Injection of hydrocortisone acetate into ankle joint |
Direct substance |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Injection of hydrocortisone acetate into shoulder joint |
Direct substance |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Injection of hydrocortisone acetate into knee joint |
Direct substance |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
hydrocortison 1 % + pramocain 1 % skumklysma |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Subcutaneous injection of hydrocortisone acetate |
Direct substance |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
hydrocortisonacetat 50 mg/ml injektionsvæske, suspension, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
hydrocortisonacetat 50 mg/ml injektionsvæske, suspension, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Product containing hydrocortisone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Product containing hydrocortisone acetate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Product containing hydrocortisone acetate in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Product containing hydrocortisone acetate in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Product containing hydrocortisone acetate in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 10 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 10 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 5 mg/g eye ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 5 mg/g eye ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 25 milligram/1 gram conventional release eye ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 25 milligram/1 gram conventional release eye ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Fusidic acid 20 mg/g and hydrocortisone acetate 10 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Fusidic acid 20 mg/g and hydrocortisone acetate 10 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
neomycin + hydrocortison 0,5 %/1,5 % øjen-/øredråber |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
neomycin + hydrocortison 0,5 %/1,5 % øjen-/øredråber |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter conventional release suspension for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter conventional release suspension for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 25 mg/mL suspension for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 25 mg/mL suspension for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 25 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 25 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 100 mg/mL rectal foam |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 100 mg/mL rectal foam |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Hydrocortisone acetate 20 mg/mL cutaneous lotion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 20 mg/mL cutaneous lotion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone (as hydrocortisone acetate) 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone acetate |
Inferred relationship |
Some |
2 |